CMR extracellular volume and T1 mapping report diffuse fibrosis
Weve excluded the companies that only offer brand-name drugs from this analysis, as the prices simply arent comparable, and there arent many good reasons to use these companies for branded GLP-1 RAs instead of just going to the doctor if you have insurance
Concomitant therapy may be already occurring naturally in everyday clinical practice, but it remains questionable whether it truly maximises cardiorenal benefits or if it could just represent a wasteful use of resources
Choose a convenient appointment slot that fits your schedulemorning, evening, or weekend consultations available
The cardiorenal effects of both GLP-1RA and SGLT-2 inhibitors can be summarized as follows: GLP-1RA have moderate benefits on MACE (major cardiovascular events), may reduce all-cause mortality and hospitalization for HF (HHF), and have a robust effect in reducing the incidence of macroalbuminuria [12]